← Leaderboards
Hong-Ming Hu
Providence Portland Medical Center
$1,630,963
Attributed
$1,630,963
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $262.5K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,630,963 · 2
By mechanism
R01$1,279,337 · 1
R21$351,626 · 1
Top collaborators
No co-investigators on record.
Most similar at Providence Portland Medical Center
Same institution · by research overlap
- Bernard A Fox$5,302,432
Others in their field
Top investigators on “Dendritic Cells”
- Barton F Haynes · Duke University$112,608,041
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- James C. Paulson · Scripps Research Institute$41,568,802
- Ulrich H Von Andrian · Harvard Medical School$32,521,007
- Donald L Morton · John Wayne Cancer Institute$29,042,629
Research focus
Dendritic CellsTumor AntigensPathway InteractionsMelanomaNovel StrategiesAntigensCross-PrimingCancer ImmunotherapyIn VitroMediatingNeoplasm MetastasisNeoplastic CellBaseBreast CarcinomaClinical TrialsCross PresentationMemoryCancer VaccinesInnovationCd8b1 GeneIn VivoLeadAntigen-Presenting CellsProteins
Grant awards (7)
Docking DRibbles to dendritic cells via C-type lectin receptors$191,796
R21 · FY2010 · CA · contact PI
Docking DRibbles to dendritic cells via C-type lectin receptors$159,830
R21 · FY2009 · CA · contact PI
TLR-mediated DC activation and immune reconstitution$248,938
R01 · FY2008 · CA · contact PI
TLR-mediated DC activation and immune reconstitution$248,938
R01 · FY2007 · CA · contact PI
TLR-mediated DC activation and immune reconstitution$256,373
R01 · FY2006 · CA · contact PI
TLR-mediated DC activation and immune reconstitution$262,544
R01 · FY2005 · CA
TLR-mediated DC activation and immune reconstitution$262,544
R01 · FY2004 · CA